2.5mg Letrozole Tablets IP

LETROZONE 2.5 is a prescription medication that contains Letrozole, a potent aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By reducing estrogen levels in the body, LETROZONE 2.5 helps inhibit the growth of certain types of breast tumors that require estrogen to grow. This medication is an integral part of hormone therapy for breast cancer management.

Key Benefits:

• Effective Breast Cancer Treatment: LETROZONE 2.5 is effective in reducing the risk of breast cancer recurrence in postmenopausal women with hormone receptor-positive breast cancer.
• Hormone Therapy: Provides a targeted approach to hormone therapy by lowering estrogen levels, which can help slow or stop the growth of hormone-sensitive tumors.
• Post-Surgery Support: Often used as an adjuvant treatment following surgery to help prevent the cancer from returning.

How Does It Work?

LETROZONE 2.5 works by inhibiting the enzyme aromatase, which is involved in the production of estrogen in the body. By blocking this enzyme, Letrozole significantly reduces estrogen levels, thereby depriving estrogen-dependent breast cancer cells of the hormone they need to grow and proliferate. This mechanism helps to slow down or even halt the progression of certain types of breast cancer.

Directions for Use:

• Dosage: The recommended dose of LETROZONE 2.5 is one tablet (2.5mg) taken once daily.
• Administration: Take the tablet orally, with or without food, at the same time each day for consistency.
• Duration: Follow your healthcare provider's instructions regarding the duration of treatment. Do not stop taking LETROZONE 2.5 without consulting your doctor.

Side Effects:

While LETROZONE 2.5 is generally well-tolerated, some patients may experience side effects, including:

• Hot Flashes: A common side effect due to reduced estrogen levels.
• Joint and Muscle Pain: Some patients report discomfort or stiffness.
• Fatigue: Feelings of tiredness or weakness can occur.
• Nausea: Mild gastrointestinal discomfort may be experienced.
• Osteoporosis: Long-term use can lead to bone thinning, so bone density monitoring may be necessary.